工程中的聚合物 细胞外囊模仿学:当前状态和前景
Xinyue Wei1, Sihang Liu1,2, Yifeng Cao1,3
1Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China.
Pharmaceutics
|May 27, 2023
概括
聚合物工程外细胞囊模拟器 (EVMs) 提供了改善的癌症药物递送效率. 本综述探讨了它们的设计和功能,用于先进的纳米医学应用.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 传统的纳米药物在维持癌症治疗的高药物输送效率方面面临着挑战.
- 细胞外囊泡 (EVs) 由于免疫性较低和高准能力,表现有前途,但存在局限性.
- 聚合物工程外细胞囊模拟器 (EVMs) 正在成为克服EV限制的解决方案.
研究的目的:
- 审查基于聚合物的细胞外囊泡在癌症药物输送中的当前状态.
- 分析EVM作为理想药物载体的结构和功能特性.
- 为推进基于EVM的药物输送系统提供见解.
主要方法:
- 在癌症治疗中模仿基于聚合物的细胞外囊泡的文献综述.
- 分析电子投票机的结构和功能特性.
- 与理想药物载体设计原则的比较.
主要成果:
- 聚合物工程电子投票机显示出在癌症治疗中增强药物加载和向输送的潜力.
- 电子投票机提供了一个可调节的平台,以克服自然电动汽车固有的局限性.
- 电子投票机的设计可以根据理想的药物载体特性进行优化.
结论:
- 基于聚合物的EVM代表了纳米医学在癌症治疗中的有希望的进步.
- 进一步了解EVM的设计和功能将加速它们的临床转化.
- 电子投票机具有显著的潜力,可以提高药物输送效率和瘤学中的治疗结果.
相关概念视频
Overview of Exosomes
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


